Begin typing your search...
Showing results for "#Oncology"
Study sheds light on epigenetic changes in cancer progression
Mutations are changes in this information that can disrupt the function of the affected proteins.
New study explains how immunotherapies don’t always work as predicted
Checkpoint blockade inhibitors do not work for at least 50% of patients whose tumours have a high mutational burden.
Director of Cancer Institute, Adyar, G Selvaluxmy passes away
Dr. Selvaluxmy was a cherished member of the oncology fraternity and was known for her dedication and her bold persona.
Lupin incorporates unit in US to focus on oncology products
Drug maker Lupin on Tuesday said it has incorporated a wholly-owned subsidiary in the US.
